SOCIETE PHARMACEUTIQUE DE GESTION
ActiveSummary
SOCIETE PHARMACEUTIQUE DE GESTION has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €50k and a net result of €24k. Equity remains stable across the filed fiscal years (±0.9% per year). Its solvency ranks better than 66% of 26043 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2024
78
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability99▲+20
Solvency76▼-2
Growth68▲+17
Track record100
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity ample (current ratio 1.83 against 1.79 in 2023; short-term debt: 49% and cash: 74.8% of total assets), and 49% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
51%
Return on assets
24.3%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
31 d late
2022
32 d late
2021
61 d late
2020
27 d late
2019
55 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Turnover
€69k▲ 4.5%
2019 · €66k
2019: €66k
2019 → 2020
EBIT margin
34.6%▲ 0.3pp
2019 · 34.4%
2019: 34.4%
2019 → 2020
Net result
€24k▲ 188%
2023 · €8k
2018: €12k
2019: €19k
2020: €18k
2021: €41k
2022: €17k
2023: €8k
2018 → 2024
Working capital
€40k▲ 9.0%
2023 · €37k
2018: €50k
2019: €34k
2020: €27k
2021: €44k
2022: €46k
2023: €37k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€69k-
Equity€27k-€68k▲ 153%€65k▼ 4.1%€52k▼ 20.1%€50k▼ 4.1%
Operating result€24k-€59k▲ 150%€33k▼ 44.2%€16k▼ 52.0%€36k▲ 127%
Net result€18k-€41k▲ 125%€17k▼ 58.2%€8k▼ 51.8%€24k▲ 188%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 127% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €98k
Fixed assets
€10k ▼ 34.6%
Current assets
€88k ▲ 6.4%
Equity and liabilities €98k
Equity
€50k ▼ 4.1%
Debt
€48k ▲ 4.3%
Debt's share of the balance-sheet total rises from 46.9% to 49.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€42k▲
2023 · €21k
Cash flow
€29k▲
2023 · €14k
Current ratio
1.83▲
2023 · 1.79
Debt to equity
0.96▲
2023 · 0.88
ROE
47.6%▲
2023 · 15.9%
ROA
24.3%▲
2023 · 8.4%
Interest coverage
462.99▲
2023 · 162.15
Debt ≤ 1 year
€48k▲
2023 · €46k
Income taxes
€12k▲
2023 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 47 lines
Balance sheet
Code20232024
Assets
Total assets20/58€98k€98k▼
Fixed assets21/28€16k€10k▼
Tangible fixed assets22/27€16k€10k▼
Furniture and vehicles24€16k€10k▼
Current assets29/58€83k€88k▲
Amounts receivable within one year40/41€4k€14k▲
Trade receivables40€3k€14k▲
Other amounts receivable41€130€34▼
Cash at bank and in hand54/58€78k€73k▼
Deferred charges and accrued income490/1€964€420▼
Equity and liabilities
Total equity and liabilities10/49€98k€98k▼
Equity10/15€52k€50k▼
Contributions10/11€6k€6k=
Capital10€6k-
Issued capital100€19k-
Uncalled capital101€12k-
Outside capital11-€6k
Other1109/19-€6k
Reserves13€46k€44k▼
Non-distributable reserves130/1€2k€2k=
Legal reserve130€2k-
Reserves not available under the articles1311-€2k
Distributable reserves133€44k€42k▼
Amounts payable17/49€46k€48k▲
Amounts payable within one year42/48€46k€48k▲
Trade debts44€2k€8k▲
Suppliers440/4€2k€8k▲
Taxes, remuneration and social security45€23k€20k▼
Taxes450/3€23k€20k▼
Other amounts payable47/48€21k€20k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k▲
Other operating charges640/8€53-
Non-recurring operating charges66A€272-
Gross operating margin9900€21k€42k▲
Operating profit (loss)9901€16k€36k▲
Financial income75/76B€965€0▼
Recurring financial income75€965€0▼
Financial charges65/66B€130€90▼
Recurring financial charges65€130€90▼
Profit (loss) for the period before taxes9903€17k€36k▲
Income taxes67/77€8k€12k▲
Profit (loss) for the period9904€8k€24k▲
Profit (loss) for the period to be appropriated9905€8k€24k▲
Appropriation of the result
Profit (loss) to be appropriated9906€8k€24k▲
Transfer from equity791/2€13k€2k▼
Profit to be distributed694/7€21k€26k▲
Return on contributions (dividend)694€21k€26k▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
08-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 31 days late
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
31-12
Financial
Weakest financial yearnet €8k ▼51.8%
Net result drops to €8k, the lowest in the series; recovery starts the following year.
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 61 days late
2021
31-12
Financial
Highest result since 2018net €41k ▲125%
Operating result €59k, net result €41k, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 27 days late
2020
24-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 55 days late
2019
22-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 22 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Lariksenstraat 21050 ElseneGround area
519 m²
Building footprint
337 m²
Volume, LiDAR
5,231 m³
Parcel 21447B0266/00K010, Brussels · tallest building 19.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
SOPHAGEST
since 20042.136.702.736
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0266/00K010 | Brussels | 519 m² | 1 · 337 m² | 19.7 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
APOTHEEK SCHEPENS
BE 0771.512.462
Tongeren-Borgloon · Eq €49,891
PHARMACIE DE L'ENTREVILLE
BE 1019.479.304
Lobbes · Eq €50,348
APHARMAT
BE 0831.853.489
Antwerpen · Eq €49,674
ARUCAREA
BE 0650.576.822
Oud-Turnhout · Eq €49,580
KLIPPER-T
BE 1015.441.827
Kapelle-op-den-Bos · Eq €49,576
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,764 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded14-04-2004
Fiscal year end31-12
Abbreviation FR
SOPHAGEST
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.